Decisions: RLIF v Mikhail Burlitskiy (RUS) and RLIF v Vadim Fedchuk (RUS)
Decisions in the cases RLIF v Mikhail Burlutskiy and RLIF v Vadim Fedchuk have been published by Sport Resolutions.
On 4th November 2016, Mr Burlutskiy and Mr Fedchuk were subject to In-Competition tests by UK Anti-Doping following a Rugby League World Cup qualifying match between Russia and Italy. Both athletes’ samples returned Adverse Analytical Findings for prohibited substances and they were made subject to provisional suspensions pending decisions of the Rugby League International Federation (RLIF) Anti-Doping Tribunal.
Mr Burlutskiy tested positive for Methylhexaneamine, a specified stimulant under category S6 of the WADA Prohibited List and is prohibited In-Competition. Mr Burlutskiy submitted that the AAF was a result of taking sports supplement ‘Mesomorph’. As the RLIF did not submit that Mr Burlutskiy’s ingestion of Methylhexaneamine was intentional, the period of ineligibility to be applied is two years. Mr Burlutskiy’s sanction will run from 04 November 2016 until midnight 03 November 2018.
Mr Fedchuk tested positive for the presence of Drostanolone (and metabolite), 19-Norandrosterone (metabolite of Nandrolone), Clenbuterol and Chorionic Gonadotrophin. The Tribunal received no evidence from Mr Fedchuk and as such, had no explanation as to how these substances entered his system. As Mr Fedchuk did not establish that his Anti-Doping Rule Violation was not intentional, the period of ineligibility to be applied is four years. Mr Fedchuk’s sanction will run from 06 January 2017 until midnight 05 January 2021.
Both RLIF Anti-Doping Tribunal decisions can be accessed via the related links tab on the right-hand side.